130 related articles for article (PubMed ID: 9748428)
1. Inhaled corticosteroid therapy reduces the early morning peak in cortisol and aldosterone.
Wilson AM; Sims EJ; Struthers AD; Lipworth BJ
Clin Sci (Lond); 1998 Oct; 95(4):513-7. PubMed ID: 9748428
[TBL] [Abstract][Full Text] [Related]
2. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
Clark DJ; Grove A; Cargill RI; Lipworth BJ
Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
[TBL] [Abstract][Full Text] [Related]
3. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
Wilson AM; McFarlane LC; Lipworth BJ
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
[TBL] [Abstract][Full Text] [Related]
4. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the effect of inhaled glucocorticosteroids by morning cortisolemia].
Cherecheş PP; Marshall DM; Ichim G; Crişan M; Nanulescu MV
Pneumologia; 2006; 55(4):182-4. PubMed ID: 17494274
[TBL] [Abstract][Full Text] [Related]
6. Controlled trial of inhaled fluticasone propionate in moderate to severe COPD.
Thompson WH; Carvalho P; Souza JP; Charan NB
Lung; 2002; 180(4):191-201. PubMed ID: 12391509
[TBL] [Abstract][Full Text] [Related]
7. Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate.
Mahachoklertwattana P; Sudkronrayudh K; Direkwattanachai C; Choubtum L; Okascharoen C
Arch Dis Child; 2004 Nov; 89(11):1055-8. PubMed ID: 15499064
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
Wilson AM; Clark DJ; Devlin MM; McFarlane LC; Lipworth BJ
Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
[TBL] [Abstract][Full Text] [Related]
9. Impact of exogenous glucocorticoid use on salivary cortisol measurements among adults with asthma and rhinitis.
Masharani U; Shiboski S; Eisner MD; Katz PP; Janson SL; Granger DA; Blanc PD
Psychoneuroendocrinology; 2005 Sep; 30(8):744-52. PubMed ID: 15919580
[TBL] [Abstract][Full Text] [Related]
10. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
11. Fluticasone inhalation in moderate cases of bronchopulmonary dysplasia.
Dugas MA; Nguyen D; Frenette L; Lachance C; St-Onge O; Fougères A; Bélanger S; Caouette G; Proulx E; Racine MC; Piedboeuf B
Pediatrics; 2005 May; 115(5):e566-72. PubMed ID: 15833887
[TBL] [Abstract][Full Text] [Related]
12. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
[TBL] [Abstract][Full Text] [Related]
13. Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate.
Gyllfors P; Dahlén SE; Kumlin M; Larsson K; Dahlén B
J Allergy Clin Immunol; 2006 Jul; 118(1):78-83. PubMed ID: 16815141
[TBL] [Abstract][Full Text] [Related]
14. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
Wilson AM; Clark DJ; McFarlane L; Lipworth BJ
Eur J Clin Pharmacol; 1997; 53(1):33-7. PubMed ID: 9349927
[TBL] [Abstract][Full Text] [Related]
15. Pituitary-adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment.
Ng PC; Fok TF; Wong GW; Lam CW; Lee CH; Wong MY; Lam K; Ma KC
J Clin Endocrinol Metab; 1998 Jul; 83(7):2390-3. PubMed ID: 9661616
[TBL] [Abstract][Full Text] [Related]
16. Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate.
Eid N; Morton R; Olds B; Clark P; Sheikh S; Looney S
Pediatrics; 2002 Feb; 109(2):217-21. PubMed ID: 11826198
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral and inhaled corticosteroid on lymphocyte beta2-adrenoceptor function in asthmatic patients.
Tan KS; McFarlane LC; Lipworth BJ
Br J Clin Pharmacol; 1997 Dec; 44(6):565-8. PubMed ID: 9431832
[TBL] [Abstract][Full Text] [Related]
18. A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids.
Nelson HS; Stricker W; Casale TB; Raff H; Fourré JA; Aron DC; Newman KB
J Clin Pharmacol; 2002 Mar; 42(3):319-26. PubMed ID: 11865969
[TBL] [Abstract][Full Text] [Related]
19. Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment.
Wilson AM; Sims EJ; Lipworth BJ
Clin Endocrinol (Oxf); 1999 Mar; 50(3):329-35. PubMed ID: 10435058
[TBL] [Abstract][Full Text] [Related]
20. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor kappaB in asthma.
Hart L; Lim S; Adcock I; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 2000 Jan; 161(1):224-31. PubMed ID: 10619824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
